Laura Johnston: GLP-1 Drugs Create New Pressures for Women

In a column for cleveland.com, columnist Laura Johnston argues that the rapid rise of GLP-1 medications brings profound cultural pressures and health concerns alongside medical benefits.

The Growth and Campus Culture of Weight-Loss Medications

More than a tenth of U.S. adults currently take GLP-1 medications for weight loss, cleveland.com reported. The pharmaceutical market is expanding from $6 billion in 2023 to a projected $100 billion by 2030, according to Goldman Sachs.

Ads promising health, ease, and sculpted biceps appear everywhere. On college campuses, students face intense appearance pressures related to sorority recruitment. “Students told me there's an 'Ozempidemic' on campuses in which everyone is taking it but nobody is talking about it,” one student told New York Magazine.

If you lie, you help create an unrealistic body standard that makes other women feel like s—.”

Medical Benefits and the Return of Skinny Worship

GLP-1 medications offer substantial health benefits for individuals with obesity and related conditions. Yet they also generate intense cultural pressure to lose weight.

The Guardian described a shift back to a noughties-level skinny worship culture, cleveland.com reported. The National Eating Disorders Association warns that using these drugs due to weight stigma or fat phobia can prove harmful.

Laura Johnston: GLP-1 Drugs Create New Pressures for Women
Photo: The Badger Herald

Layla Taylor from the Secret Lives of Mormon Wives weighed 99 pounds at 5-foot-10 and called her GLP-1 an “unhealthy crutch” that fueled her eating disorder, cleveland.com reported.

Campus Perspectives and Health Uncertainties

Buses around Madison display advertisements for GLP-1 weight-loss study treatments, The Badger Herald reported. Young people receive messages that smaller bodies are inherently healthier and more beautiful, according to Madison-area sources cited by The Badger Herald.

“We are telling young people that smaller bodies are inherently healthier and more beautiful and more attractive,” Mascolo said. University of Pennsylvania Medicine notes that no protocol currently screens patients for eating disorders prior to prescribing GLP-1 medications.

Palmberg said that while the drugs help treat Type 2 diabetes, individuals far from clinical overweight status use them unnecessarily.

“I think it is having a negative impact on individuals since it’s becoming a very common trend, which a weight loss medication shouldn’t become a trend,” Palmberg told The Badger Herald.

Common Questions About Weight-Loss Drug Trends

What are GLP-1 medications primarily used to treat medically?

Medications such as Ozempic are mainly used to treat individuals with Type 2 diabetes by helping manage blood sugar levels, according to the Cleveland Clinic via The Badger Herald.

What financial growth is projected for the GLP-1 industry?

The industry is growing from $6 billion in 2023 to a predicted $100 billion in 2030, according to Goldman Sachs figures cited by cleveland.com.

How large was the college student study cohort in the referenced research?

A study conducted by Washington University-St. Louis surveyed nearly 30,000 students from universities across the U.S., The Badger Herald reported.

Founded in 1969 as a conservative alternative to the campus daily, The Badger Herald serves the University of Wisconsin–Madison community with a print circulation of 6,000 and a staff of nearly 100 students.

The paper publishes Monday through Friday during the academic year and is funded solely by advertising revenue, having consistently refused university subsidies to maintain editorial independence. By 1992 it had overtaken the older Daily Cardinal to become the dominant newspaper on the 40,000-student campus.

Where can individuals seek help for eating disorders?

Individuals can contact the National Eating Disorder Association at (800) 931-2237 or chat online at www.nationaleatingdisorders.org, The Badger Herald reported.